¹Ì±¹º´¿ø¾à»ç ÇÙ½É CPS¸¦ ¾Æ½Ã³ª¿ä

ÀÓ»ó¾àÇÐÀÇ º¯È­ÇÏ´Â ¸ð½À ¸®¾óÇÏ°Ô È®ÀÎ

±â»çÀÔ·Â 2012-08-03 11:30     ÃÖÁ¾¼öÁ¤ 2012-08-04 11:03 ÇÁ¸°Æ®Çϱ⠸ÞÀϺ¸³»±â ½ºÅ©·¦Çϱ⠸ñ·Ïº¸±â   ÆùƮũ°Ô ÆùÆ®ÀÛ°Ô

ÇöÀç ¹Ì±¹³» º´¿ø¾à»çµéÀÇ ¿ªÇÒÀÌ ÃÖ±Ùµé¾î Å©°Ô º¯È­Çϰí ÀÖ´Ù. ƯÈ÷  CP(Clinical Pharmacist)¿Í CPS(Clinical Pharmacy Specialist)ÀÇ ÀڰݱâÁذú ¿ªÇÒÀ» ¾ö°ÝÈ÷ ±¸ºÐÇÔÀ¸·Î½á ÀÓ»ó ¾àÇÐ Áö½ÄÀ» ÇÑ´Ü°è ¾÷±×·¹À̵å ÇÏ·Á´Â ³ë·ÂµéÀÌ È®¿¬ÇØ Áö°í ÀÖ´Ù. ´ÙÀ½¿¡ ¼Ò°³µÇ´Â ³»¿ëÀº ÇöÀç º»Áö¿¡ ÀýÂù¸®¿¡ ¿¬ÀçµÇ°í ÀÖ´Â 'SUN & VINNYÀÇ ÀÓ»ó¾àÇÐÀ̾߱â'ÀÇ ÀϺÎÀÌ´Ù.

Clinical Pharmacist vs. Clinical Pharmacy Specialist

CP ¿Í CPS ¿ªÈ°ÀÇ Â÷À̰¡ ¹«¾ùÀΰ¡ ¶Ç ÀÚ°Ý Á¶°ÇÀÌ ¾î¶»°Ô ´Ù¸¥°¡?   ÃÖ±Ù Çѱ¹ÀÇ ¸ð º´¿ø ¾à»ç¿¡°Ô ¹ÞÀº Áú¹®ÀÌ´Ù.

ÇÊÀÚ(CP)°¡ follow up Çϰí Àִ  febrile neutropenia ¼Ò¾Æ¾Ï ȯÀÚÀÇ pharmacy clinical note ¸¦ ¾Æ·¡¿¡ ´Þ¾Æ ³õ¾Ò´Ù.

Pharmacy Note/Focus: Vancomycin pre/post levels

AW is a 8 yom for febrile neutropenia w/ (+) blood/urine cultures.  Vancomycin 325mg IVPB q 8 h initiated with levels to be drawn around 4th dose.   Pharmacy consulted to evaluate levels and make any necessary dosing adjustments if needed.

Ht: 132 cm  ABW: 22.9 kg  WBC:  2.3   BUN/SCr: 7/0.41  Tmax: 39.5 C
Cultures:  Blood (drawn 7/24): (+) Staph. aureus   Urine (drawn 7/22): (+) Staph. aureus

Vancomycin levels:

Pre: 5.2 mg/L (drawn 7/26 @ 0832), Preceding dose given 7/26 @ 0115
Post: 18.5 mg/L (drawn 7/26 @ 1121)

Kinetic values:  Kel: 0.211/hr   T 1/2: 3 hr   Vd:  0.91 L/kg

Pharmacy Plan:  Pre and post levels are both subtherapeutic. Recommend dosing frequency to q 6 h in order to increase levels to therapeutic goal range of 10-15 mg/L considering patient's current diagnosis.  Will consider another set order of pre/post levels once steady state is reached if long term treatment is deemed appropriate.  Plan discussed with/approved by John Doe, Pediatric Clinical Pharmacy Specialist.  Please call with questions/concerns.   Thank You.

CPÀÇ ÁÖ¿ä ÀÓ¹« Áß Çϳª´Â À§¿Í °°ÀÌ pharmacodynamic dosing consult ¸¦ ÅëÇÑ better therapeutic outcomes ÀÇ ÁöÇâÀÌ´Ù.     CP ÀÇ ÀÚ°Ý Á¶°ÇÀº, PG1 & 2 ¸¦ °ÅÄ£ ¾à»çµµ ÀÖÁö¸¸ ´ëºÎºÐÀº º´¿ø¸¶´Ù  ÀÚüÀûÀ¸·Î ¸¸µé¾î ³õÀº competency ¸¦ Åë°úÇÑ ¾à»çµéÀÌ´Ù.   

Level 1, 2, 3 °°Àº ÀÏÁ¾ÀÇ ´Ù´Ü°è ½É»ç ±âÁØÀ» ¸¸µé¾î ÀÏÁ¤ ±â°£¾È¿¡ ½ÃÇèÀ» Åë°úÇØ¾ß ÇÏ´Â º´¿øµµ ÀÖ´Ù.   º´¿ø¿¡ µû¶ó CP°¡ ÇÒ ¼ö ÀÖ´Â pharmacy therapeutic intervention Á¾·ù¿Í ¹üÀ§´Â Â÷À̰¡ ÀÖ´Ù.  

Àα٠¼ººó¼¾Æ® º´¿ø CP´Â antibiogram°ú ȯÀÚÀÇ º´·Â/Lab results¸¦ °ËÅäÇÏ°í ¾à»çÀÇ Àç·®¿¡ µû¶ó Ç×»ýÁ¦¸¦ ¼±ÅÃÇÑ´Ù.   ¶Ç ´Ù¸¥ Áö¿ª º´¿øÀº, ¾à»ç°¡ ȯÀÚÀÇ pain assay ½Ç½Ã ÈÄ ÁøÅë¾àÀÇ Á¾·ù¿Í continuous IV infusionÀÏ °æ¿ì pump parameter setting À» ÇÑ´Ù.   ´Ù½Ã Çѹø °­Á¶ÇÏÀÚ¸é, ¾à»çÀÇ pharmacy therapeutic interventionÀº º´¿ø ¸¶´Ù P&T policy ¾È¿¡¼­ Á¤µµ¿Í ¹üÀ§¸¦ ±ÔÁ¤Çϰí Àֱ⿡ therapeutic deviation À» ¹Ì¿¬¿¡ ¹æÁöÇÒ ¼ö ÀÖ´Ù.

CPS ´Â ÀڱⰡ ¸ÃÀº º´µ¿ ȯÀÚµéÀÇ physician clinical note/ pharmacy clinical progress note¸¦ °ËÅäÇÔÀ¸·Î ÇÏ·ç Àϰú¸¦ ½ÃÀÛÇÑ´Ù.   ¾Õ Ä®·³¿¡¼­ ÇÊÀÚ´Â CPS ÀÇ ¿ªÈ°¿¡ ´ëÇØ ¼³¸íÇÏ¿´±â¿¡ ¿©±â¼­´Â »ý·«Çϱâ·Î ÇÑ´Ù.    CPS ´Â ÆÊµð ÇÐÀ§°¡ Çʼö Á¶°ÇÀº ¾Æ´ÏÁö¸¸ CP ¸¦ °ÅÃÄ PG1, PG2 ¼ö·á´Â ±âº»À̰í BCPS ÀڰݱîÁö °®Ãß¾î¾ß ÇÏ´Â °ÍÀÌ º¸ÅëÀÌ´Ù.  

ÇÊÀÚ º´¿ø CPS´Â ÁÖ¸»/¾ß°£/°øÈÞÀÏ ±Ù¹«°¡ ¾ø°í °¢ÀÚÀÇ ½ºÄÉÁÙÀ» ½º½º·Î °ü¸®ÇÏ´Â µî ±ÝÀü¿Ü ÇýÅÃ(?)ÀÌ ÀÖ´Ùº¸´Ï ¿¬ºÀÀº CP¿Í º°¹Ý ´Ù¸£Áö ¾Ê´Ù.   CPS´Â È£Ãâ±â¸¦ Ç׽à ¼ÒÁöÇÏ¿© ÈÞ°¡±â°£À» Á¦¿ÜÇϰï 24 ½Ã°£ ¿¬¶ôÀÌ °¡´ÉÇÏ¿©¾ß ÇÑ´Ù.   ÇÊÀÚ°¡ ±Ù¹«ÇÏ´Â Àεð¾Ö³ª ÁÖ¸³´ëÇÐ ÀÇ´ë ºÎ¼Ó º´¿øÀº Å©°í ÀÛÀº 19 °³ÀÇ ¸ÞµðÄà ķÆÛ½º¿Í ¿¬±¸¼Ò·Î ±¸¼ºµÇ¾î ÀÖ´Ù.   

°¢ ¸ÞµðÄà ķÆÛ½ºÀÇ CPS µéÀº Á¤±âÀûÀÎ ¸ðÀÓÀ» °¡Áö°í °øÅëÀÇ °ü½É»ç¸¦ ³íÀÇÇÏÁö¸¸ °¢ Ä·ÆÛ½º Ư¼º¿¡ ¸Â´Â pharmacy therapeutic protocol À» °¡Áö°í ÀÖ´Ù.  Àü¹ø Ä®·³¿¡¼­ Àá±ñ ¾ð±ÞÇßÁö¸¸ º¸´Ù Àü¹®¼ºÀ» °¡Áø CPS µµ ÀÖ´Ù.  

Áö³­ ÁÖ Àå±â À̽ÄÀ» ÇÑ ÈÄ IV tacolimus ¸¦ Åõ¾à¹Þ´Â ȯÀÚ°¡ ÁßȯÀڽǿ¡ ÀÔ¿øÇÏ¿´´Ù.   ´ã´çÀÇ´Â CP¿¡°Ô tacolimus ¸¦ IV¿¡¼­ sublingual route ·Î ÀüÈ¯ÇØÁÙ °ÍÀ» ºÎŹÇÏ¿´´Âµ¥ °æ±¸°¡ ¾Æ´Ñ ¼³ÇÏÁ¦ Åõ¾à¿¡ ´ëÇÑ ¿ë·®°ú ¿ë¹ý ÀÚ¹®À» À§ÇØ Transplant clinical pharmacy specialist ¿¡ µµ¿òÀ» ±¸ÇÏ¿© ÀÚ¼¼ÇÑ Á¤º¸¸¦ ¹ÞÀº ÀûÀÌ ÀÖ´Ù.

ÇÊÀÚ : ÀÓ¼º¶ô ¾à»ç(¿À¸¥ÂÊ)¿Í Vincent Polito ¾à»ç(¿ÞÂÊ)¡ã ÇÊÀÚ : ÀÓ¼º¶ô ¾à»ç(¿À¸¥ÂÊ)¿Í Vincent Polito ¾à»ç(¿ÞÂÊ)
ÃÖ±Ù ¿¬¹æ Á¤ºÎ ±â°ü º´¿øÀ» Áß½ÉÀ¸·Î ±âÁ¸ÀÇ CP µé¿¡°Ô ¹Ý°­Á¦ÀûÀ¸·Î PG1 À» À̼öÇϵµ·Ï ÇÏ´Â pilot program À» ½ÃÀÛÇÏ¿´´Ù.  ÁÖ´ç 40 ½Ã°£ ±Ù¹« Áß 20 ½Ã°£Àº PG 1 clerkship¿¡ ÇÒ¾ÖÇÏ°í ³ª¸ÓÁö 20 ½Ã°£Àº Á¤»ó ±Ù¹«¸¦ Çϴµ¥, À̼ö ¸øÇÒ °æ¿ì ¿¬ºÀ¿¡ ºÒÀÌÀÍÀ» ÁÖ¾î ±Ã±ØÀûÀ¸·Î CP µéÀÇ ÀÓ»ó ¾àÇÐ Áö½ÄÀ» ÇÑ´Ü°è ¾÷±×·¹À̵å ÇÏ·Á´Â ½ÃµµÀÌ´Ù.   

ÇÊÀÚ º´¿øÀÇ °æ¿ì, ½ÅûÀÚ¿¡ ÇÑÇØ CP¿¡°Ô PG1 & 2 °úÁ¤À» À̼öÇÒ ±âȸ¸¦ Áִµ¥, ½ÇÁö ±Ù¹« ½Ã°£Àº ÁÙ¾îµé±â¿¡ ¿¬ºÀÀº ±×¸¸Å­ ³·¾ÆÁø´Ù.    ÇöÀç À̰÷ ¹Ì±¹ÀÇ ÀÓ»ó ¾àÇÐÀº °è¼ÓÇØ¼­ ÁøÈ­ ÁßÀÌ´Ù.

[¿¬Àç¹°  - Sun & VinnyÀÇ ÀÓ»ó ¾àÇÐ À̾߱â]

±â»ç°øÀ¯   Æ®À§ÅÍ   ÆäÀ̽ººÏ   ¹ÌÅõµ¥ÀÌ   ¿äÁò   ½ÎÀ̰ø°¨   ±¸±Û
µ¶ÀÚ Àǰ߳²±â±â

µ¶ÀÚÀǰ߾²±â   ¿î¿µ¿øÄ¢º¸±â

(0/500ÀÚ) ·Î±×ÀÎ

¸®Çôޱâ

´ñ±Û °³   ¼û±â±â

µ¶ÀÚÀǰß(´ñ±Û)À» ´Þ¾ÆÁÖ¼¼¿ä.

´º½ºÈ¨À¸·Î    ÀÌÀüÆäÀÌÁö·Î    ¸ÇÀ§·Î

Àαâ±â»ç    ´ñ±Û´Þ¸°±â»ç    °ø°¨±â»ç

½Ç½Ã°£ ´ñ±Û ´õº¸±â

¿ÀÇǴϾð ´õº¸±â

»ç¶÷µé interview

¡°¡®One-stop¡¯ ¼­ºñ½º¡¤ Á¦Ç° µî·Ï¼º°ø 100%¿¡ µµÀü¡±

¾¾¿£¾Ë¸®¼­Ä¡ Áß±¹Áö»ç ¹ÚõÀÏ »çÀå

´õº¸±â

±¸ÀÎ    ±¸Á÷   ¸Å¸Å

ÀǾàÁ¤º¸ ´õº¸±â

À§Ã༺ À§¿°ÀÇ È¿°úÀûÀÎ °ü¸®

ÀÚ±ÃÀ¯¼¶À¯Á¾_ ±èûȣ / °ú¹Î¼º´ëÀåÁõÈıº¾à / ÄÚ¿¢½º¾à±¹

¾à¾÷ºÏ¸ô    ½Å°£¾È³»

2013³âÆÇ ¾à»ç¿¬°¨

¾à¾÷°è À¯ÀÏÇÑ Á¤Ã¥ÀÚ·áÁý¡¦ Àι°Á¤º¸ ÃѸÁ¶ó

ÆÊÇ÷¯½º ´õº¸±â